This is the recording of the regular press briefing of European Medicines Agency on COVID-19 vaccines and therapeutics that took place on 21 December 2021.

00:00 Introduction
01:42 Update from Emer Cooke, Executive Director, EMA
12:57 Update on authorisations of COVID-19 vaccines and treatments (as of 21.12.2021)
20:34 Questions from journalists
20:59 Omicron specific vaccine
26:03 Novavax vaccine, Moderna's booster dose and antivirals
29:24 Antivirals: how long are they effective against severe disease
31:25 COVID-19 Vaccines and menstrual troubles
35:25 Nasal vaccines for COVID-19
36:59 Pregnancy and mRNA vaccines for COVID-19 (which trimester is better for vaccination?)
38:00 Wrap-up

EMA Speakers:
Emer Cooke, Executive Director
Marco Cavaleri, Head of Biological Health Threats and Vaccines Strategy
Georgy Genov, Head of Pharmacovigilance

EMA Moderator:
Marie-Agnes Heine, Head of Communication

#EMAPresser #COVID19

свернуть